More from the series Subscribe: Apple Podcasts Spotify Injectable peptide therapy, a controversial wellness trend that caught fire online in 2025, shows no signs of slowing down in 2026, despite an overwhelming lack of safety data
Deyama S, Bang E, Kato T, Li XY, Duman RS
In medicine, we have a saying: when something claims to do everything, it usually does nothingor its overriding fundamental biological safety mechanisms
Research shows that in senescent cells, p53 levels are maintained low through ubiquitination while its pro-apoptotic activity is repressed through nuclear segregation by FOXO4. The peptide's competitive inhibition restores p53 activity by promoting nuclear exclusion, allowing p53 to execute its pro-apoptotic program and eliminate senescent cells through targeted pathway activation
Our peptides, including our widely-used IGF-1 LR3, are made through small-batch synthesis right here in the United States
Factors That Influence Your Personal Timeline The timeline above is typical, but several factors shape how fast you personally see results
